CN106290907A - 全血中血清淀粉样蛋白a定量检测试剂以及检测方法 - Google Patents
全血中血清淀粉样蛋白a定量检测试剂以及检测方法 Download PDFInfo
- Publication number
- CN106290907A CN106290907A CN201610639622.8A CN201610639622A CN106290907A CN 106290907 A CN106290907 A CN 106290907A CN 201610639622 A CN201610639622 A CN 201610639622A CN 106290907 A CN106290907 A CN 106290907A
- Authority
- CN
- China
- Prior art keywords
- reagent
- mass percent
- whole blood
- serum amyloid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 130
- 101710190759 Serum amyloid A protein Proteins 0.000 title claims abstract description 76
- 210000004369 blood Anatomy 0.000 title claims abstract description 54
- 239000008280 blood Substances 0.000 title claims abstract description 51
- 102000054727 Serum Amyloid A Human genes 0.000 title claims abstract description 49
- 238000001514 detection method Methods 0.000 title claims abstract description 24
- 239000000872 buffer Substances 0.000 claims abstract description 42
- 239000003755 preservative agent Substances 0.000 claims abstract description 35
- 230000002335 preservative effect Effects 0.000 claims abstract description 35
- 239000004094 surface-active agent Substances 0.000 claims abstract description 35
- 239000003792 electrolyte Substances 0.000 claims abstract description 34
- 239000003381 stabilizer Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 26
- 239000004816 latex Substances 0.000 claims abstract description 21
- 229920000126 latex Polymers 0.000 claims abstract description 21
- 239000002245 particle Substances 0.000 claims abstract description 16
- -1 reaction promoter Substances 0.000 claims abstract description 7
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 4
- 238000005259 measurement Methods 0.000 claims abstract description 4
- 238000002835 absorbance Methods 0.000 claims description 18
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 16
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
- 238000004458 analytical method Methods 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 238000003556 assay Methods 0.000 claims description 9
- 238000011088 calibration curve Methods 0.000 claims description 9
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 8
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 8
- 229920000053 polysorbate 80 Polymers 0.000 claims description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 6
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 6
- 229930182566 Gentamicin Natural products 0.000 claims description 6
- 239000004471 Glycine Substances 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000007983 Tris buffer Substances 0.000 claims description 6
- 239000013504 Triton X-100 Substances 0.000 claims description 6
- 229920004890 Triton X-100 Polymers 0.000 claims description 6
- 229940098773 bovine serum albumin Drugs 0.000 claims description 6
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 claims description 4
- 239000005711 Benzoic acid Substances 0.000 claims description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 4
- LWZFANDGMFTDAV-WYDSMHRWSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-WYDSMHRWSA-N 0.000 claims description 4
- 235000010233 benzoic acid Nutrition 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 229960003511 macrogol Drugs 0.000 claims description 4
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 4
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 4
- 239000000344 soap Substances 0.000 claims description 4
- 235000010288 sodium nitrite Nutrition 0.000 claims description 4
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical class C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 claims description 4
- 235000011067 sorbitan monolaureate Nutrition 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 229940077388 benzenesulfonate Drugs 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 229950008882 polysorbate Drugs 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 230000005611 electricity Effects 0.000 claims description 2
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 229910001414 potassium ion Inorganic materials 0.000 claims description 2
- 229910001415 sodium ion Inorganic materials 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000000306 component Substances 0.000 abstract description 8
- 210000005259 peripheral blood Anatomy 0.000 abstract description 3
- 239000011886 peripheral blood Substances 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 description 31
- 239000000203 mixture Substances 0.000 description 17
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 8
- 102000009091 Amyloidogenic Proteins Human genes 0.000 description 7
- 108010048112 Amyloidogenic Proteins Proteins 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 4
- 108700028909 Serum Amyloid A Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 238000010219 correlation analysis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 238000011017 operating method Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101001006906 Rattus norvegicus T-kininogen 1 Proteins 0.000 description 1
- 101001006907 Rattus norvegicus T-kininogen 2 Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 101000609411 Sus scrofa Inter-alpha-trypsin inhibitor heavy chain H4 Proteins 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N2021/3185—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry typically monochromatic or band-limited
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610639622.8A CN106290907B (zh) | 2016-08-03 | 2016-08-03 | 全血中血清淀粉样蛋白a定量检测试剂以及检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610639622.8A CN106290907B (zh) | 2016-08-03 | 2016-08-03 | 全血中血清淀粉样蛋白a定量检测试剂以及检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106290907A true CN106290907A (zh) | 2017-01-04 |
CN106290907B CN106290907B (zh) | 2018-07-06 |
Family
ID=57665703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610639622.8A Active CN106290907B (zh) | 2016-08-03 | 2016-08-03 | 全血中血清淀粉样蛋白a定量检测试剂以及检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106290907B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107656069A (zh) * | 2017-09-28 | 2018-02-02 | 宁波普瑞柏生物技术股份有限公司 | 全血中全量程c‑反应蛋白定量检测试剂及方法 |
CN107860929A (zh) * | 2017-11-10 | 2018-03-30 | 苏州康和顺医疗技术有限公司 | 一种血清淀粉样蛋白a的免疫比浊检测试剂和方法 |
CN110108531A (zh) * | 2019-05-14 | 2019-08-09 | 深圳天深医疗器械有限公司 | 一种排除医学检测中血细胞干扰的方法 |
CN110806483A (zh) * | 2019-10-25 | 2020-02-18 | 深圳市理邦精密仪器股份有限公司 | 血清淀粉样蛋白a的浓度测量方法及装置 |
CN111965342A (zh) * | 2020-08-11 | 2020-11-20 | 武汉生之源生物科技股份有限公司 | 一种提高胶乳免疫比浊法线性范围和稳定性的方法、试剂及试剂盒 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989008261A1 (en) * | 1988-03-02 | 1989-09-08 | Erling Sundrehagen | Composition for simple detection and/or quantification of antigenic substances in body liquids |
JP2006017745A (ja) * | 2005-09-26 | 2006-01-19 | Eiken Chem Co Ltd | 免疫学的粒子凝集反応方法 |
CN101881777A (zh) * | 2010-06-30 | 2010-11-10 | 深圳市国赛生物技术有限公司 | 超敏c反应蛋白检测方法及超敏c反应蛋白检测试剂盒 |
CN104655843A (zh) * | 2014-05-19 | 2015-05-27 | 宁波普瑞柏生物技术有限公司 | 一种胃癌检测方法、试剂以及其试剂盒 |
CN105203771A (zh) * | 2015-09-14 | 2015-12-30 | 绍兴圣康生物科技有限公司 | 一种血清淀粉样蛋白a测定试剂盒及其使用方法 |
CN105372434A (zh) * | 2015-08-13 | 2016-03-02 | 浙江卓运生物科技有限公司 | 人血清淀粉样蛋白a检测试剂盒 |
CN105548571A (zh) * | 2016-02-02 | 2016-05-04 | 潍坊三维生物工程集团有限公司 | 检测血清淀粉样蛋白a含量的试剂盒、方法及用途 |
-
2016
- 2016-08-03 CN CN201610639622.8A patent/CN106290907B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989008261A1 (en) * | 1988-03-02 | 1989-09-08 | Erling Sundrehagen | Composition for simple detection and/or quantification of antigenic substances in body liquids |
JP2006017745A (ja) * | 2005-09-26 | 2006-01-19 | Eiken Chem Co Ltd | 免疫学的粒子凝集反応方法 |
CN101881777A (zh) * | 2010-06-30 | 2010-11-10 | 深圳市国赛生物技术有限公司 | 超敏c反应蛋白检测方法及超敏c反应蛋白检测试剂盒 |
CN104655843A (zh) * | 2014-05-19 | 2015-05-27 | 宁波普瑞柏生物技术有限公司 | 一种胃癌检测方法、试剂以及其试剂盒 |
CN105372434A (zh) * | 2015-08-13 | 2016-03-02 | 浙江卓运生物科技有限公司 | 人血清淀粉样蛋白a检测试剂盒 |
CN105203771A (zh) * | 2015-09-14 | 2015-12-30 | 绍兴圣康生物科技有限公司 | 一种血清淀粉样蛋白a测定试剂盒及其使用方法 |
CN105548571A (zh) * | 2016-02-02 | 2016-05-04 | 潍坊三维生物工程集团有限公司 | 检测血清淀粉样蛋白a含量的试剂盒、方法及用途 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107656069A (zh) * | 2017-09-28 | 2018-02-02 | 宁波普瑞柏生物技术股份有限公司 | 全血中全量程c‑反应蛋白定量检测试剂及方法 |
CN107860929A (zh) * | 2017-11-10 | 2018-03-30 | 苏州康和顺医疗技术有限公司 | 一种血清淀粉样蛋白a的免疫比浊检测试剂和方法 |
CN110108531A (zh) * | 2019-05-14 | 2019-08-09 | 深圳天深医疗器械有限公司 | 一种排除医学检测中血细胞干扰的方法 |
CN110108531B (zh) * | 2019-05-14 | 2022-02-11 | 深圳天深医疗器械有限公司 | 一种排除医学检测中血细胞干扰的方法 |
CN110806483A (zh) * | 2019-10-25 | 2020-02-18 | 深圳市理邦精密仪器股份有限公司 | 血清淀粉样蛋白a的浓度测量方法及装置 |
CN111965342A (zh) * | 2020-08-11 | 2020-11-20 | 武汉生之源生物科技股份有限公司 | 一种提高胶乳免疫比浊法线性范围和稳定性的方法、试剂及试剂盒 |
CN111965342B (zh) * | 2020-08-11 | 2023-08-29 | 武汉生之源生物科技股份有限公司 | 一种提高胶乳免疫比浊法线性范围和稳定性的方法、试剂及试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN106290907B (zh) | 2018-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101377492B (zh) | 胱抑素c测定试剂盒 | |
CN102628864B (zh) | 胶乳增强免疫比浊法测定血清或尿液中心脏型脂肪酸结合蛋白的试剂盒 | |
CN106290907B (zh) | 全血中血清淀粉样蛋白a定量检测试剂以及检测方法 | |
Ruhl et al. | Upper limits of normal for alanine aminotransferase activity in the United States population | |
CN102621332B (zh) | 基于胶乳粒子包被视黄醇结合蛋白检测试剂盒 | |
Karon et al. | Comparison of lactate values between point-of-care and central laboratory analyzers | |
ES2707073T3 (es) | Enfoque de aplicación múltiple para la determinación fotométrica de un analito en una muestra de fluido en un analizador automatizado | |
CN109596843B (zh) | 一种血清淀粉样蛋白a的测定试剂盒 | |
CN107656069A (zh) | 全血中全量程c‑反应蛋白定量检测试剂及方法 | |
CN106568978A (zh) | 血清淀粉样蛋白a检测方法及试剂 | |
Panteghini | Present issues in the determination of troponins and other markers of cardiac damage | |
CN102636653A (zh) | 复合胶乳粒子包被胱抑素c检测试剂盒 | |
Guder et al. | The haemolytic, icteric and lipemic sample recommendations regarding their recognition and prevention of clinically relevant interferences. Recommendations of the Working Group on Preanalytical Variables of the German Society for Clinical Chemistry and the German Society for Laboratory Medicine | |
US10073103B1 (en) | Rapid measurement of total vitamin D in blood | |
CN107860929A (zh) | 一种血清淀粉样蛋白a的免疫比浊检测试剂和方法 | |
CN106324251B (zh) | 小片段BMG抗体的制备方法及β2-微球蛋白检测试剂盒 | |
CN103389383A (zh) | 一种测定血清中肌红蛋白含量的检测试剂盒 | |
CN107462731B (zh) | 一种免疫球蛋白a检测试剂盒及检测方法 | |
CN107462729B (zh) | 一种载脂蛋白a1检测试剂盒及检测方法 | |
JP5055507B2 (ja) | 試料中のタンパク質の測定方法及び測定試薬 | |
CN103728455B (zh) | 一种测定Kappa游离轻链浓度的试剂盒及方法 | |
CN107490675B (zh) | 一种免疫比浊试剂盒及检测方法 | |
CN107478853B (zh) | 一种载脂蛋白b检测试剂盒及检测方法 | |
CN109946295A (zh) | 一种尿微量白蛋白免疫透射比浊法检测试剂盒 | |
CN112763731B (zh) | 一种脂蛋白(a)测定试剂盒及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 315033 999 Tonghui Road, C District, Jiangbei District, Ningbo, Zhejiang Applicant after: Ningbo Purui Bai biotechnology Limited by Share Ltd Address before: 315033 TONGNING Road, C District, Jiangbei District, Ningbo, Zhejiang, 288 Applicant before: PUREBIO LABORATORIES (NINGBO) LTD. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Reagent and method for quantitatively detecting serum amyloid proteins A in whole blood Effective date of registration: 20191206 Granted publication date: 20180706 Pledgee: Bank of Ningbo Co., Ltd. Jiangbei sub branch Pledgor: Ningbo Purui Bai biotechnology Limited by Share Ltd Registration number: Y2019330000261 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200813 Granted publication date: 20180706 Pledgee: Bank of Ningbo Co.,Ltd. Jiangbei sub branch Pledgor: NINGBO PUREBIO BIOTECHNOLOGY Co.,Ltd. Registration number: Y2019330000261 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Reagent and method for quantitative detection of serum amyloid A in whole blood Effective date of registration: 20211108 Granted publication date: 20180706 Pledgee: Bank of Ningbo Co., Ltd. Yinzhou sub branch Pledgor: Ningbo prebo Biotechnology Co., Ltd Registration number: Y2021330002163 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |